首页 正文

Protection against cyclophosphamide-induced myelosuppression by ZPDC glycoprotein (24 kDa)

{{output}}
Immunomodulatory agents are often used to reduce myelosuppression and enhance immune response for cancer treatment. Cyclophosphamide (CTX) can induce oxidative stress in bone marrow resulting in suppression of anti-oxdiantive enzymes and causes myelosuppressio... ...